Atlas Trials

Study of the Steroid Sparing Effect of Xolair (Omalizumab) in Patients With Persistent Eosinophilic Bronchitis

Clinical trial NCT02049294 · COMPLETED

Trial details

NCT number
NCT02049294
Sponsor
McMaster University
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Steroid and/or Prednisone Dependent AsthmaEosinophilic Bronchitis
Start date
2014-03-01
Primary completion
2017-09-01
Enrollment
11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.